147 related articles for article (PubMed ID: 8436239)
1. Regional isolated perfusion with melphalan for patients with subungual melanoma.
Vrouenraets BC; Kroon BB; Klaase JM; van Geel BN; Eggermont AM; Mooi WJ; van Dongen JA
Eur J Surg Oncol; 1993 Feb; 19(1):37-42. PubMed ID: 8436239
[TBL] [Abstract][Full Text] [Related]
2. Regional perfusion for the treatment of subungual melanoma.
Muchmore JH; Krementz ET; Carter RD; Sutherland CM; Godfrey RS
Am Surg; 1990 Feb; 56(2):114-8. PubMed ID: 2306053
[TBL] [Abstract][Full Text] [Related]
3. Isolated regional perfusion in the treatment of subungual melanoma.
Baas PC; Hoekstra HJ; Schraffordt Koops H; Oosterhuis JW; Oldhoff J
Arch Surg; 1989 Mar; 124(3):373-6. PubMed ID: 2645858
[TBL] [Abstract][Full Text] [Related]
4. Surgical management and prognostic factors in patients with subungual melanoma.
Heaton KM; el-Naggar A; Ensign LG; Ross MI; Balch CM
Ann Surg; 1994 Feb; 219(2):197-204. PubMed ID: 8129491
[TBL] [Abstract][Full Text] [Related]
5. Single-centre prospective study of isolated limb perfusion with melphalan in the treatment of subungual malignant melanoma.
Lingam MK; McKay AJ; Mackie RM; Aitchison T
Br J Surg; 1995 Oct; 82(10):1343-5. PubMed ID: 7489159
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma of the toenail apparatus.
Hayes IM; Thompson JF; Quinn MJ
J Am Coll Surg; 1995 May; 180(5):583-8. PubMed ID: 7749535
[TBL] [Abstract][Full Text] [Related]
7. Subungual melanoma: Management in the modern era.
Reilly DJ; Aksakal G; Gilmour RF; Gyorki DE; Chauhan A; Webb A; Henderson MA
J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1746-1752. PubMed ID: 28888486
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
[TBL] [Abstract][Full Text] [Related]
9. Nail-bed melanoma.
Klausner JM; Inbar M; Gutman M; Weiss G; Skornick Y; Chaichik S; Rozin RR
J Surg Oncol; 1987 Mar; 34(3):208-10. PubMed ID: 3821128
[TBL] [Abstract][Full Text] [Related]
10. Melanoma arising under the nail.
Papachristou DN; Fortner JG
J Surg Oncol; 1982 Dec; 21(4):219-22. PubMed ID: 7144198
[TBL] [Abstract][Full Text] [Related]
11. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiology and prognosis of subungual melanoma].
Paul E; Kleiner H; Bödeker RH
Hautarzt; 1992 May; 43(5):286-90. PubMed ID: 1612918
[TBL] [Abstract][Full Text] [Related]
13. Isolated limb perfusion for stage I melanoma of the extremity: a comparison of melphalan and dacarbazine (DTIC).
Edwards MJ; Boddie AW; Ames FC; McBride CM
South Med J; 1989 Aug; 82(8):985-7, 989. PubMed ID: 2762904
[TBL] [Abstract][Full Text] [Related]
14. The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma.
Grunhagen DJ; de Wilt JH; Graveland WJ; van Geel AN; Eggermont AM
Cancer; 2006 Jan; 106(1):156-62. PubMed ID: 16323177
[TBL] [Abstract][Full Text] [Related]
15. Regional chemotherapy for melanoma. A 35-year experience.
Krementz ET; Carter RD; Sutherland CM; Muchmore JH; Ryan RF; Creech O
Ann Surg; 1994 Oct; 220(4):520-34; discussion 534-5. PubMed ID: 7944662
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting survival after complete response to isolated limb perfusion in patients with in-transit melanoma.
Zogakis TG; Bartlett DL; Libutti SK; Liewehr DJ; Steinberg SM; Fraker DL; Alexander HR
Ann Surg Oncol; 2001 Dec; 8(10):771-8. PubMed ID: 11776490
[TBL] [Abstract][Full Text] [Related]
17. Subungual melanoma: management considerations.
Cohen T; Busam KJ; Patel A; Brady MS
Am J Surg; 2008 Feb; 195(2):244-8. PubMed ID: 18086464
[TBL] [Abstract][Full Text] [Related]
18. Confirmatory trial of non-amputative digit preservation surgery for subungual melanoma: Japan Clinical Oncology Group study (JCOG1602, J-NAIL study protocol).
Tanaka K; Nakamura Y; Mizutani T; Shibata T; Tsutsumida A; Fukuda H; Matsushita S; Aoki M; Namikawa K; Ohe S; Fukushima S; Yamazaki N;
BMC Cancer; 2019 Oct; 19(1):1002. PubMed ID: 31653251
[TBL] [Abstract][Full Text] [Related]
19. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
Hansson JA; Simert G; Vang J
Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
[TBL] [Abstract][Full Text] [Related]
20. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.
Liénard D; Eggermont AM; Koops HS; Kroon B; Towse G; Hiemstra S; Schmitz P; Clarke J; Steinmann G; Rosenkaimer F; Lejeune FJ
Melanoma Res; 1999 Oct; 9(5):491-502. PubMed ID: 10596916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
